Enanta Pharmaceuticals to Participate at Jefferies Global Healthcare C...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 24, 2024

Arbor Day Foundation’s ‘Canopy Report’ Examines How America Sees Trees • White House Correspondents’ Association Dinner to Welcome Hooman Shahidi, Co-founder and CEO of EVPassport, the Rapidly Gr • Arcosa Publishes 2023 Sustainability Report • The Birches at Concord Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Strai • Santiago, Chile Will Host the 2027 Special Olympics World Games • ACTS LAW Addresses Federal Correctional Institution in Dublin Controversy • Orion S.A. Earns Platinum Sustainability Rating by EcoVadis • Wounded Warrior Project, White House Celebrate and Honor Warriors at Annual Soldier Ride • Leading Industry Publication: Black & Veatch Remains Among Global Critical Infrastructure Leaders as Sustainability, Decarbo • Motlow State Community College Expands Accessibility With the Addition of YuJa Panorama Digital Accessibility Platform to Its Ed • QuantumScape Reports First Quarter 2024 Business and Financial Results • The Village at Willow Crossings Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Th • ERVIN COHEN & JESSUP PARTNER RECOGNIZED AS TOP LAWYER IN LOS ANGELES • Ouro Teams Up with Texas One Fund with Multi-Year NIL X World Wallet Financial Empowerment Program for University of Texas Stude • Benchmark Senior Living at Hamden Assisted Living Community Named One of the Country's Best by U.S. News & World Report • Middlebrook Farms at Trumbull Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Thir • ESS Inc. Schedules First Quarter 2024 Financial Results Conference Call • Bay Square at Yarmouth Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Strai • PONIX AWARDED $5 MILLION USDA GRANT TO BREAK "GROUND" ON CLIMATE-SMART AGRICULTURE IN GEORGIA • WM Announces First Quarter 2024 Earnings

Enanta Pharmaceuticals to Participate at Jefferies Global Healthcare Conference

WATERTOWN, Mass. , May 31 /Businesswire/ - Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at Jefferies Global Healthcare Conference on June 7, 2023 at 12:30 p.m. ET in New York, NY.

A live webcast of the event will be accessible by visiting the “Events and Presentations” section on the “Investors” page of Enanta’s website at www.enanta.com. A replay of the webcast will be available following the presentation and will be archived for at least 30 days.

About Enanta Pharmaceuticals, Inc.

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections. Enanta’s research and development programs include clinical candidates for the following disease targets: respiratory syncytial virus (RSV), SARS-CoV-2 (COVID-19) and hepatitis B virus (HBV). Enanta is also conducting research on a single agent targeting both RSV and human metapneumovirus (hMPV).

Enanta receives royalties from hepatitis C virus (HCV) products developed under its collaboration with AbbVie. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic HCV infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET® (U.S.) and MAVIRET® (ex-U.S.) (glecaprevir/pibrentasvir). Please visit www.enanta.com for more information.